Livongo Health Target of Unusually High Options Trading (NASDAQ:LVGO)

Livongo Health (NASDAQ:LVGO) was the target of some unusual options trading activity on Wednesday. Investors acquired 2,942 put options on the stock. This is an increase of approximately 3,030% compared to the average volume of 94 put options.

Livongo Health stock opened at $21.20 on Thursday. Livongo Health has a 52 week low of $15.12 and a 52 week high of $45.68. The business’s 50 day moving average price is $20.14.

Livongo Health (NASDAQ:LVGO) last posted its earnings results on Wednesday, November 6th. The company reported ($0.05) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.28) by $0.23. The firm had revenue of $46.70 million for the quarter, compared to the consensus estimate of $42.77 million. During the same period in the prior year, the business earned ($0.55) EPS. Livongo Health’s quarterly revenue was up 148.7% compared to the same quarter last year. On average, sell-side analysts forecast that Livongo Health will post -1.29 earnings per share for the current year.

Several equities analysts recently weighed in on LVGO shares. Chardan Capital started coverage on shares of Livongo Health in a research report on Friday, August 16th. They issued a “neutral” rating and a $40.00 price target on the stock. Zacks Investment Research raised shares of Livongo Health from a “sell” rating to a “hold” rating in a research report on Saturday, November 2nd. Morgan Stanley raised shares of Livongo Health from an “equal weight” rating to an “overweight” rating and set a $42.00 target price on the stock in a research report on Wednesday, August 28th. Needham & Company LLC started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set a “buy” rating and a $42.00 target price on the stock. Finally, Goldman Sachs Group started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set a “buy” rating and a $43.00 target price on the stock. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $44.20.

Several hedge funds have recently modified their holdings of LVGO. Rhumbline Advisers purchased a new stake in shares of Livongo Health during the 3rd quarter worth approximately $238,000. Dean Capital Investments Management LLC purchased a new stake in shares of Livongo Health during the 3rd quarter worth approximately $275,000. Pembroke Management LTD purchased a new stake in shares of Livongo Health during the 3rd quarter worth approximately $1,128,000. Emerald Mutual Fund Advisers Trust purchased a new stake in shares of Livongo Health during the 3rd quarter worth approximately $1,292,000. Finally, Emerald Advisers LLC purchased a new stake in shares of Livongo Health during the 3rd quarter worth approximately $1,342,000. Institutional investors own 0.10% of the company’s stock.

About Livongo Health

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Further Reading: Book Value Of Equity Per Share – BVPS Explained

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.